News for hackers. Stuff that matters.

A comment on Sloan Kettering’s Deal with Startup Ignites a New Uproar. Parent comment

Re:Sloan Kettering’s Deal with Startup Ignites a New Uproar by forapurpose on Monday September 24, 2018 @07:05PM (#18062248)
> which is anonymized

How reliably is the anonymization? Based on very little reading, data can at least sometime be de-anonymized. If that becomes possible 5 years from now, what happens then to the data already made public? How will individual's privacy be protected?

[ Parent | on HN ]
Re:Sloan Kettering’s Deal with Startup Ignites a New Uproar by itronitron on Monday September 24, 2018 @08:14PM (#18062597)
Unless they are in the business of selling advertisements or life insurance, there is probably very little incentive for them to de-anonymize the data. The bigger risk with that data is that they don't secure it properly.
[ Parent | on HN ]
Re:Sloan Kettering’s Deal with Startup Ignites a New Uproar by sulam on Monday September 24, 2018 @07:48PM (#18062474)
My understanding is that these are pathology samples. I don't know what metadata may be associated with them, of course. Just the samples and the diagnoses would give very little for re-identification to work on.
[ Parent | on HN ]